Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
artificial blood substitute
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:advantage |
does not require blood typing
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:color |
dark purple
|
| gptkbp:component |
hemoglobin-based oxygen carrier
|
| gptkbp:contains |
modified human hemoglobin
|
| gptkbp:designedFor |
trauma patients
|
| gptkbp:developedBy |
gptkb:Northfield_Laboratories
|
| gptkbp:discontinued |
2009
|
| https://www.w3.org/2000/01/rdf-schema#label |
PolyHeme
|
| gptkbp:intendedUse |
emergency treatment of severe blood loss
|
| gptkbp:regulates |
not approved
|
| gptkbp:riskFactor |
adverse cardiovascular events
increased mortality in some studies |
| gptkbp:storageAdvantage |
longer shelf life than donated blood
|
| gptkbp:bfsParent |
gptkb:Blood_Substitute
|
| gptkbp:bfsLayer |
7
|